Home » Fda » What does OCTGT (CBER) mean in Fda?

OCTGT (CBER) in Fda Meaning

The OCTGT (CBER) meaning in Fda terms is "Office of Cellular, Tissue and Gene Therapies (CBER)". There are 1 related meanings of the OCTGT (CBER) Fda abbreviation.

OCTGT (CBER) on Fda Full Forms

  1. Office of Cellular, Tissue and Gene Therapies (CBER)

Frequently Asked Questions (FAQ)

  1. What does OCTGT (CBER) stand for Fda?

    OCTGT (CBER) stands for Office of Cellular, Tissue and Gene Therapies (CBER) in Fda terms.

  2. What is the shortened form of Office of Cellular, Tissue and Gene Therapies (CBER) in Fda?

    The short form of "Office of Cellular, Tissue and Gene Therapies (CBER)" is OCTGT (CBER) for Fda.

Citation

OCTGT (CBER) in Fda. Acronym24.com. (2020, May 24). Retrieved June 26, 2024 from https://acronym24.com/octgt-cber-meaning-in-fda/

Last updated